<DOC>
	<DOCNO>NCT00395226</DOCNO>
	<brief_summary>Rosacea common chronic dermatological condition , characterize recurrent persistent redness , permanent dilation small blood vessel cause small red lesion , papules/pustules . The sign rosacea usually confine face , may appear neck , scalp trunk . Opthalmologic finding also common . Rosacea usually describe common fair skin woman 40 . The purpose study determine whether oral Zinc Sulfate treatment effective treatment facial rosacea .</brief_summary>
	<brief_title>Zinc Sulfate Treatment Rosacea : A Randomized , Controlled Trial</brief_title>
	<detailed_description>Rosacea common chronic dermatological condition . The epidemiology rosacea determine extensively , due part problem case definition . Rosacea usually describe common fair skin woman age 40 . However occur adult population , include men woman age , people many complexion type , include African Americans Asians . Although rosacea encounter frequently primary care dermatology practice , precise incidence prevalence know . The etiology pathogenesis rosacea unknown . Both genetic environmental factor think important . A wide range medical surgical intervention use management rosacea , include dietary management , topical systemic antibiotic , azelaic acid , low dose isotretinoin , laser treatment telangiectasia rhinophyma . No single regimen find entirely satisfactory . Zinc find effective manage several dermatological condition , especially acne . It also find benefit dermatological condition viral wart cutaneous leishmaniasis . No study publish use Zinc treatment rosacea . This prospective , double blind , randomize , control trial , compare effect supplemental placebo severity rosacea . Enrolled subject assign one two study arm . Subjects investigator blind regard treatment . After evaluation , meeting study criterion , obtain informed consent , initiate study related procedure , subject take oral study drug placebo , bid , 90 day . Subjects follow via phone call one week 6 week enrollment study . At conclusion 90 day study , subject re-examined . The primary endpoint study severity rosacea end 90 day intervention period . The efficacy Zinc vs. placebo assess comparison change severity rosacea .</detailed_description>
	<mesh_term>Rosacea</mesh_term>
	<mesh_term>Zinc</mesh_term>
	<mesh_term>Zinc Sulfate</mesh_term>
	<criteria>Diagnosis facial rosacea make confirm one investigator . Severity sign rosacea `` great mild '' time enrollment . Treatment rosacea 3 month prior enrollment . Use zinc dietary supplement &gt; 25 mg per day 3 month prior enrollment ( Most patient take multivitamin Zinc , often 15 mg per day , exclude , whereas patient take additional Zinc supplement , often 2550 mg per day exclude . ) Diagnosis rosacea fulminancy . Pregnant breast feeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Rosacea</keyword>
</DOC>